Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2004 by Genentech, Inc..
Recruitment status was  Active, not recruiting
Information provided by:
Genentech, Inc. Identifier:
First received: November 24, 2004
Last updated: June 23, 2005
Last verified: November 2004
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2004
  Estimated Primary Completion Date: No date given